Hla-a Locus Typing

What is HLA-A Locus Typing test?

An HLA-A locus typing test identifies a person's specific Human Leukocyte Antigen-A (HLA-A) genes, which are crucial for immune system function and tissue compatibility. Specific HLA-A gene variants are linked to an increased susceptibility to certain autoimmune conditions.

Why consider HLA-A Locus Typing test?

The results are used to ensure a safe organ or bone marrow transplant by matching donor and recipient compatibility, thereby minimizing rejection, and can also provide insights into certain autoimmune diseases or drug sensitivities. 

• Transplant compatibility: HLA‑A mismatches contribute to alloimmune risk; accurate HLA‑A typing improves donor selection, match grading, and immunosuppression planning in solid organ and HSCT workflows.
• Antibody interpretation: Knowing precise HLA‑A alleles helps interpret class I donor‑specific antibodies on solid‑phase assays and anticipate crossmatch outcomes to reduce rejection risk.
• Comprehensive profiling: HLA‑A typing complements other loci (B, C, DR, DQ, ±DP) to form a complete histocompatibility profile used by transplant programs and registries.

Who should get tested for HLA-A Locus Typing test?

Transplant candidates and potential donors: Individuals evaluated for kidney, liver, heart, lung, or HSCT where HLA information guides allocation and compatibility decisions.

Sensitized recipients: Patients with class I antibodies who need precise HLA‑A allele data for virtual crossmatch and risk stratification before donor offers.

Donor registries/cord units: Typing at HLA‑A with other loci improves search efficiency and match quality for unrelated donor selection.

More Information about HLA-A Locus Typing test

HLA is central to transplant compatibility: matching donor and recipient HLA types and ensuring no donor‑specific HLA antibodies are present reduces rejection risk, improves graft survival, and guides immunosuppression strategies. A mismatch between a donor's and recipient's HLAs can trigger an immune response, leading to graft (transplanted organ or tissue) rejection. HLA matching aims to find a donor whose HLAs are as similar as possible to the recipient's, which increases the likelihood of graft acceptance and reduces the risk of rejection and other complications.

OTHER NAMES: HLA‑A typing / HLA‑A allele typing, High‑resolution HLA‑A genotyping, HLA class I (A locus) DNA typing.